KYMR Kymera Therapeutics, Inc. - Common Stock
$124,12
Fiyat · Ağu 19, 2026
Temel veriler itibarıyla Ağu 5, 2026
52 Haftlık Aralık
$40–$130
93% of range
Analist Derecelendirmesi
BUY
30 analysts
Fiyat Hedefi
$131
+5% upside
P/E (TTM)
-33.6
ROE
-24.4%
Net Kâr Marjı
-794.0%
Kymera Therapeutics, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
KYMR Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$124.12
Piyasa Değeri
$10.09B
P/E (TTM)
-33.6
EPS (TTM)
$-3.69
Gelir (TTM)
$39M
Temettü Verimi
—
ROE
-24.4%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$40 – $130
KYMR Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$39M
2019-12-31
→
2025-12-31
Hisse Başına Kâr
$-3.69
2020-12-31
→
2025-12-31
Serbest Nakit Akışı
$-234M
2020-12-31
→
2025-12-31
Marjlar
-794.0%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
KYMR
Akran Ortalaması
P/E (TTM)
-33.6
16.0
P/S (TTM) (F/S (TTM))
257.4
32.5
P/B (F/D)
6.4
3.9
Price / FCF (Fiyat / Serbest Nakit Akışı)
-43.1
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
KYMR
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
-891.1%
—
Net Profit Margin (Net Kâr Marjı)
-794.0%
-93.3%
ROA
-22.9%
-22.2%
ROE
-24.4%
-37.6%
ROIC
-22.1%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
KYMR
Akran Ortalaması
Current Ratio (Cari Oran)
10.5
5.7
Quick Ratio (Cari Oran)
4.3
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
KYMR
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
-16.7%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
-5.7%
—
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
2.9%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
KYMR
Akran Ortalaması
KYMR Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
30 analist
- Güçlü Al 10 33,3%
- Al 16 53,3%
- Tut 4 13,3%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
22 analist · 2026-08-16
Medyan
$133.00
Şimdi
$124.12
Düşük
$111.00
Yüksek
$155.00
Medyan hedef
$133.00
+7,2%
Ortalama hedef
$130.91
+5,5%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.00%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $-0.62 | $-0.73 | 0.11% |
| 31 Mart 2026 | $-0.71 | $-0.90 | 0.19% |
| 31 Aralık 2025 | $-0.97 | $-0.81 | -0.16% |
| 30 Eylül 2025 | $-0.94 | $-0.82 | -0.12% |
| 30 Haziran 2025 | $-0.95 | $-0.83 | -0.12% |
| 31 Mart 2025 | $-0.82 | $-0.93 | 0.11% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| KYMR | $6.33B | -21.1 | -16.7% | -794.0% | -24.4% | — |
| CYTK | $7.81B | -9.7 | 376.6% | -891.6% | 152.7% | — |
| PRAX | $7.43B | -21.9 | 249.5% | — | -47.3% | — |
| SMMT | $13.56B | -12.1 | — | — | -235.1% | — |
| PTGX | $5.47B | -42.6 | -89.4% | -282.8% | -20.3% | — |
| APGE | $5.16B | -17.9 | — | — | — | — |
| KRYS | $7.20B | 36.0 | 33.9% | 52.6% | 18.1% | — |
| IONS | $12.92B | -33.2 | — | — | -68.1% | — |
| SYRE | $2.56B | 10.1 | -62.0% | — | -26.5% | — |
| IMVT | $5.07B | -9.0 | 229.2% | — | -73.7% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 15
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $39M | $47M | $79M | $47M | $73M | $34M | $3M | |
| Cost of Revenue | $39M | $47M | $79M | $47M | · | · | · | |
| R&D Expense | $317M | $240M | $189M | $164M | $137M | $62M | $37M | |
| SG&A Expense | $68M | $64M | $55M | $44M | $36M | $18M | $8M | |
| Operating Expenses | $389M | $309M | $244M | $208M | $173M | $80M | $45M | |
| Operating Income | $-349M | $-262M | $-166M | $-161M | $-101M | $-46M | $-42M | |
| Other Non-op | $38M | $38M | $19M | $6M | $313.0K | $711.0K | $959.0K | |
| Pretax Income | $-311M | · | · | · | · | · | · | |
| Income Tax | $0 | · | · | $0 | $0 | $0 | $0 | |
| Net Income | $-311M | $-224M | $-147M | $-155M | $-100M | $-46M | $-41M | |
| EPS (Basic) | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 | $-3.15 | · | |
| EPS (Diluted) | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 | $-3.15 | · | |
| Shares (Basic) | 84,490,585 | 75,043,991 | 58,365,499 | 53,933,229 | 47,989,023 | 17,349,582 | · | |
| Shares (Diluted) | 84,490,585 | 75,043,991 | 58,365,499 | 53,933,229 | 47,989,023 | 17,349,582 | · | |
| EBITDA | $-341M | $-254M | $-162M | $-158M | $-98M | $-45M | · |
Bilanço 21
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $357M | $120M | $110M | $68M | $48M | $31M | $76M | |
| Receivables | $0 | $0 | $15M | $0 | · | · | · | |
| Prepaid Expense | $23M | $22M | $12M | $10M | $9M | $5M | $888.0K | |
| Current Assets | $871M | $510M | $405M | $419M | $451M | $302M | $93M | |
| PP&E (Net) | $43M | $50M | $48M | $13M | $12M | $11M | $4M | |
| PP&E (Gross) | $65M | $67M | $59M | $20M | $16M | $13M | $5M | |
| Accum. Depreciation | $22M | $16M | $10M | $7M | $4M | $2M | $1M | |
| Other Non-current Assets | $9M | $2M | $2M | $3M | $2M | $30.0K | $2M | |
| Total Assets | $1.74B | $978M | $576M | $603M | $606M | $487M | $117M | |
| Accounts Payable | $4M | $6M | $7M | $4M | $4M | $4M | $3M | |
| Accrued Liabilities | $42M | $35M | $34M | $28M | $23M | $10M | $5M | |
| Current Liabilities | $83M | $68M | $86M | $71M | $93M | $111M | $35M | |
| Capital Leases | $67M | $72M | $77M | $12M | $13M | $14M | $17M | |
| Other Non-current Liabilities | · | $0 | $0 | $248.0K | $66.0K | $100.0K | · | |
| Total Liabilities | $163M | $142M | $181M | $113M | $146M | $203M | $82M | |
| Common Stock | $8.0K | $7.0K | $6.0K | $6.0K | $5.0K | $4.0K | · | |
| Retained Earnings | $-1.07B | $-755M | $-531M | $-384M | $-229M | $-129M | $-76M | |
| AOCI | $2M | $-1M | $-552.0K | $-5M | $-660.0K | $-128.0K | $6.0K | |
| Stockholders' Equity | $1.58B | $836M | $395M | $490M | $460M | $284M | $-74M | |
| Liabilities + Equity | $1.74B | $978M | $576M | $603M | $606M | $487M | $117M | |
| Shares Outstanding | 81,323,532 | 64,890,193 | 55,585,305 | 55,039,380 | 51,536,181 | 44,482,186 | 1,929,516 |
Nakit Akışı 9
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $7M | $4M | $3M | $2M | $2M | $825.0K | |
| Stock-based Comp | $60M | $55M | $43M | $35M | $25M | $5M | $1M | |
| Other Non-cash | $10M | $-33M | $-3M | $-37M | $-56M | $127M | · | |
| Operating Cash Flow | $-233M | $-195M | $-103M | $-153M | $-129M | $88M | $18M | |
| CapEx | $1M | $13M | $34M | $3M | $2M | $9M | $532.0K | |
| Investing Cash Flow | $-521M | $-404M | $140M | $21M | $-100M | $-423M | $-16M | |
| Financing Cash Flow | $991M | $609M | $4M | $153M | $250M | $289M | $35M | |
| Net Change in Cash | $237M | $10M | $41M | $20M | $21M | $-45M | $36M | |
| Free Cash Flow | $-234M | $-207M | $-137M | $-156M | $-131M | $79M | · |
Kârlılık 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -891.1% | -555.8% | -210.6% | -344.4% | -138.0% | -136.1% | · | |
| Net Margin | -794.0% | -475.6% | -187.0% | -330.6% | -137.6% | -134.0% | · | |
| Pretax Margin | -794.0% | · | · | · | · | · | · | |
| EBITDA Margin | -869.9% | -540.2% | -206.1% | -338.0% | -134.7% | -130.9% | · | |
| ROA | -22.9% | -28.8% | -24.9% | -25.6% | -18.3% | -15.1% | · | |
| ROE | -24.4% | -25.9% | -37.2% | -30.9% | -21.3% | -15.8% | · | |
| ROIC | -22.1% | · | · | · | · | · | · |
Likidite ve Solventlik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.5 | 7.5 | 4.7 | 5.9 | 4.9 | 2.7 | · | |
| Quick Ratio | 4.3 | 1.8 | 1.5 | 1.0 | 0.5 | 0.3 | · |
Verimlilik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | · | |
| Receivables Turnover | · | 6.3 | 10.5 | · | · | · | · |
Büyüme Oranları 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -16.7% | -40.1% | 67.8% | -35.7% | 114.0% | · | · | |
| Revenue CAGR 3Y | -5.7% | -13.5% | 32.2% | · | · | · | · | |
| Revenue CAGR 5Y | 2.9% | · | · | · | · | · | · |
Değerleme (TTM) 10
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $39M | $47M | $79M | $47M | $73M | $34M | · | |
| Net Income TTM | $-311M | $-224M | $-147M | $-155M | $-100M | $-46M | · | |
| Market Cap | $6.33B | $2.61B | · | $1.37B | $3.27B | $2.76B | · | |
| P/E | -21.1 | -13.5 | -10.1 | -8.7 | -30.4 | -19.7 | · | |
| P/S | 161.4 | 55.5 | · | 29.3 | 44.9 | 81.0 | · | |
| P/B | 4.0 | 3.1 | · | 2.8 | 7.1 | 9.7 | · | |
| P / Tangible Book | 4.0 | 3.1 | · | 2.8 | 7.1 | 9.7 | · | |
| P / Cash Flow | -27.2 | -13.4 | · | -9.0 | -25.4 | 31.3 | · | |
| P / FCF | -27.0 | -12.6 | · | -8.8 | -25.1 | 34.9 | · | |
| Earnings Yield | -4.7% | -7.4% | -9.9% | -11.5% | -3.3% | -5.1% | · |
Gelir Tablosu 14
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $65M | $34M | $3M | $3M | $11M | $22M | $7M | $4M | $26M | $10M | $48M | $5M | $17M | $9M | $16M | $10M | |
| Cost of Revenue | $65M | $34M | $3M | $3M | $11M | $22M | $7M | $4M | $26M | $10M | · | · | · | · | · | · | |
| R&D Expense | $119M | $98M | $84M | $74M | $78M | $80M | $72M | $60M | $59M | $49M | $53M | $48M | $46M | $42M | $43M | $44M | |
| SG&A Expense | $21M | $20M | $17M | $17M | $18M | $16M | $16M | $15M | $17M | $14M | $14M | $14M | $14M | $13M | $12M | $11M | |
| Operating Expenses | $141M | $119M | $101M | $95M | $96M | $97M | $88M | $76M | $77M | $68M | $67M | $62M | $60M | $55M | $55M | $54M | |
| Operating Income | $-76M | $-84M | $-98M | $-93M | $-85M | $-74M | $-81M | $-72M | $-51M | $-58M | $-19M | $-58M | $-43M | $-45M | $-39M | $-45M | |
| Other Non-op | $14M | $15M | $11M | $10M | $8M | $9M | $10M | $10M | $9M | $9M | $5M | $5M | $5M | $4M | $4M | $2M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | $100.0K | $100.0K | $0 | · | $0 | |
| Net Income | $-61M | $-69M | $-87M | $-82M | $-77M | $-66M | $-71M | $-62M | $-42M | $-49M | $-14M | $-53M | $-39M | $-41M | $-35M | $-43M | |
| EPS (Basic) | $-0.62 | $-0.71 | $-0.98 | $-0.94 | $-0.95 | $-0.82 | $-0.89 | $-0.82 | $-0.58 | $-0.69 | $-0.25 | $-0.90 | $-0.67 | $-0.70 | $-0.59 | $-0.79 | |
| EPS (Diluted) | $-0.62 | $-0.71 | $-0.98 | $-0.94 | $-0.95 | $-0.82 | $-0.89 | $-0.82 | $-0.58 | $-0.69 | $-0.25 | $-0.90 | $-0.67 | $-0.70 | $-0.59 | $-0.79 | |
| Shares (Basic) | 98,177,158 | 97,534,269 | -163,405,637 | 87,300,286 | 80,449,405 | 80,146,531 | -144,911,702 | 76,125,975 | 73,059,398 | 70,770,320 | -116,570,361 | 58,421,859 | 58,326,963 | 58,187,038 | -104,025,850 | 54,535,514 | |
| Shares (Diluted) | 98,177,158 | 97,534,269 | -163,405,637 | 87,300,286 | 80,449,405 | 80,146,531 | -144,911,702 | 76,125,975 | 73,059,398 | 70,770,320 | -116,570,361 | 58,421,859 | 58,326,963 | 58,187,038 | -104,025,850 | 54,535,514 | |
| EBITDA | $-76M | $-82M | · | $-93M | $-85M | $-72M | · | $-72M | $-51M | $-56M | · | $-58M | $-43M | $-44M | · | $-45M |
Bilanço 21
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $124M | $144M | $357M | $113M | $336M | $90M | $120M | $111M | $68M | $94M | $110M | $81M | $52M | $50M | $68M | $156M | |
| Receivables | $20M | · | · | · | $40M | · | · | $0 | $0 | $0 | · | · | · | · | · | · | |
| Prepaid Expense | $26M | $27M | $23M | $23M | $23M | $18M | $22M | $17M | $14M | $15M | · | $14M | $14M | $11M | · | $9M | |
| Current Assets | $737M | $677M | $871M | $528M | $728M | $501M | $510M | $569M | $525M | $537M | · | $376M | $385M | $412M | · | $494M | |
| PP&E (Net) | $40M | $42M | $43M | $45M | $49M | $49M | $50M | $51M | $52M | $49M | · | $36M | $27M | $17M | · | $13M | |
| PP&E (Gross) | $66M | $66M | $65M | $67M | $69M | $67M | $67M | $65M | $64M | $60M | · | $46M | $36M | $25M | · | $19M | |
| Accum. Depreciation | $26M | $24M | $22M | $22M | $20M | $18M | $16M | $14M | $12M | $11M | · | $10M | $9M | $8M | · | $6M | |
| Other Non-current Assets | $7M | $8M | $9M | $7M | $5M | $3M | $2M | $0 | $2M | $2M | · | $3M | $3M | $3M | · | $3M | |
| Total Assets | $1.65B | $1.67B | $1.74B | $1.10B | $1.13B | $918M | $978M | $1.03B | $826M | $868M | · | $552M | $582M | $614M | · | $638M | |
| Accounts Payable | $9M | $13M | $4M | $6M | $6M | $10M | $6M | $6M | $7M | $7M | · | $5M | $4M | $6M | · | $6M | |
| Accrued Liabilities | $48M | $35M | $42M | $29M | $28M | $23M | $35M | $27M | $24M | $16M | · | $26M | $22M | $19M | · | $25M | |
| Current Liabilities | $71M | $63M | $83M | $72M | $88M | $59M | $68M | $67M | $62M | $56M | · | $63M | $55M | $62M | · | $91M | |
| Capital Leases | $64M | $66M | $67M | $68M | $70M | $71M | $72M | $74M | $75M | $76M | · | $77M | $71M | $64M | · | $12M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $8.0K | $230.0K | $237.0K | · | $256.0K | |
| Total Liabilities | $136M | $129M | $163M | $156M | $160M | $132M | $142M | $142M | $141M | $157M | · | $157M | $147M | $152M | · | $126M | |
| Common Stock | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Retained Earnings | $-1.20B | $-1.14B | $-1.07B | $-979M | $-897M | $-820M | $-755M | $-684M | $-621M | $-579M | · | $-516M | $-464M | $-425M | · | $-349M | |
| AOCI | $-7M | $-4M | $2M | $2M | $279.0K | $-58.0K | $-1M | $2M | $-2M | $-2M | · | $-2M | $-4M | $-3M | · | $-6M | |
| Stockholders' Equity | $1.51B | $1.54B | $1.58B | $946M | $971M | $786M | $836M | $893M | $685M | $711M | $395M | $396M | $435M | $462M | $490M | $513M | |
| Liabilities + Equity | $1.65B | $1.67B | $1.74B | $1.10B | $1.13B | $918M | $978M | $1.03B | $826M | $868M | · | $552M | $582M | $614M | · | $638M | |
| Shares Outstanding | 82,788,253 | 82,182,101 | 81,323,532 | 71,741,174 | 70,557,442 | 65,112,714 | 64,890,193 | 64,748,226 | 61,572,383 | 61,353,146 | · | 55,450,239 | 55,390,259 | 55,276,226 | · | 54,751,429 |
Nakit Akışı 9
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $891.0K | $895.0K | $900.0K | $879.0K | $818.0K | $767.0K | |
| Stock-based Comp | $19M | $16M | $14M | $16M | $15M | $14M | $14M | $15M | $14M | $12M | $11M | $12M | $11M | $9M | $9M | $9M | |
| Other Non-cash | · | $-38M | · | · | · | $-30M | · | · | · | $-4M | · | · | · | $-13M | · | · | |
| Operating Cash Flow | $-54M | $-89M | $-67M | $-27M | $-60M | $-79M | $-62M | $-50M | $-43M | $-40M | $8M | $-32M | $-35M | $-44M | $-40M | $-34M | |
| CapEx | $473.0K | $434.0K | $106.0K | $181.0K | $695.0K | $467.0K | $936.0K | $-189.0K | $5M | $7M | $12M | $8M | $11M | $4M | $373.0K | $1M | |
| Investing Cash Flow | $20M | $-143M | $-394M | $-235M | $60M | $49M | $69M | $-158M | $16M | $-331M | $19M | $61M | $36M | $25M | $-50M | $-37M | |
| Financing Cash Flow | $14M | $19M | $705M | $40M | $246M | $258.0K | $3M | $251M | $1M | $354M | $2M | $-206.0K | $1M | $1M | $2M | $150M | |
| Net Change in Cash | $-20M | $-213M | $244M | $-223M | $246M | $-30M | $10M | $43M | $-26M | $-16M | $29M | $29M | $2M | $-18M | $-87M | $79M | |
| Free Cash Flow | · | $-89M | · | · | · | $-80M | · | · | · | $-47M | · | · | · | $-48M | · | · |
Kârlılık 5
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -116.3% | -244.9% | · | -3347.4% | -736.8% | -336.8% | · | -1927.9% | -198.5% | -562.2% | · | -1216.4% | -262.7% | -478.8% | · | -469.9% | |
| Net Margin | -94.2% | -201.5% | · | -2973.0% | -667.6% | -296.8% | · | -1670.3% | -164.0% | -472.0% | · | -1118.2% | -235.0% | -432.4% | · | -450.2% | |
| EBITDA Margin | -116.3% | -239.0% | · | -3347.4% | -736.8% | -327.5% | · | -1927.9% | -198.5% | -548.0% | · | -1216.4% | -262.7% | -469.5% | · | -469.9% | |
| ROA | -4.4% | -5.3% | · | -7.7% | -7.8% | -7.3% | · | -7.9% | -6.0% | -6.6% | · | -8.9% | -7.0% | -7.0% | · | -6.7% | |
| ROE | -4.9% | -5.9% | · | -8.9% | -9.2% | -8.8% | · | -9.7% | -7.5% | -8.3% | · | -11.6% | -9.3% | -9.2% | · | -8.6% |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.3 | 10.8 | · | 7.4 | 8.3 | 8.5 | · | 8.5 | 8.5 | 9.6 | · | 5.9 | 7.1 | 6.6 | · | 5.4 | |
| Quick Ratio | 2.0 | 2.3 | · | 1.6 | 4.3 | 1.5 | · | 1.7 | 1.1 | 1.7 | · | 1.3 | 1.0 | 0.8 | · | 1.7 |
Verimlilik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 2.2 | · | · | · | 0.6 | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 10
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $114M | $71M | · | $40M | $63M | $62M | · | $44M | $57M | $41M | · | $40M | $47M | $40M | · | $51M | |
| Net Income TTM | $-289M | $-294M | · | $-287M | $-247M | $-219M | · | $-206M | $-182M | $-181M | · | $-176M | $-163M | $-161M | · | $-149M | |
| Market Cap | $9.49B | $6.84B | · | $4.06B | $3.08B | $1.78B | · | $3.06B | $1.84B | $2.47B | · | $771M | $1.27B | $1.64B | · | $1.19B | |
| P/E | -35.6 | -24.4 | · | -16.0 | -13.8 | -9.4 | · | -15.8 | -10.5 | -13.6 | · | -4.5 | -7.8 | -9.9 | · | -7.7 | |
| P/S | 83.6 | 96.8 | · | 101.3 | 48.9 | 28.8 | · | 69.0 | 32.1 | 60.2 | · | 19.1 | 27.1 | 40.8 | · | 23.4 | |
| P/B | 6.3 | 4.4 | · | 4.3 | 3.2 | 2.3 | · | 3.4 | 2.7 | 3.5 | · | 1.9 | 2.9 | 3.5 | · | 2.3 | |
| P / Tangible Book | 6.3 | 4.4 | · | 4.3 | 3.2 | 2.3 | · | 3.4 | 2.7 | 3.5 | · | 1.9 | 2.9 | 3.5 | · | 2.3 | |
| P / Cash Flow | · | -77.0 | · | · | · | -22.5 | · | · | · | -62.3 | · | · | · | -37.3 | · | · | |
| P / FCF | · | -76.7 | · | · | · | -22.4 | · | · | · | -52.5 | · | · | · | -34.1 | · | · | |
| Earnings Yield | -2.8% | -4.1% | · | -6.2% | -7.3% | -10.6% | · | -6.3% | -9.5% | -7.4% | · | -22.0% | -12.8% | -10.1% | · | -13.1% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $39M | $47M | $79M | $47M | $73M |
| Faaliyet Kâr Marjı % | -891.1% | -555.8% | -210.6% | -344.4% | -138.0% |
| Net Gelir | $-311M | $-224M | $-147M | $-155M | $-100M |
| Seyreltilmiş Hisse Başı Kâr | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 10.5 | 7.5 | 4.7 | 5.9 | 4.9 |
| Cari Oran | 4.3 | 1.8 | 1.5 | 1.0 | 0.5 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-234M | $-207M | $-137M | $-156M | $-131M |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 305 dosya · $8.0B toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 58 (+19 önceki Ç'ye göre) | 22 (-14 önceki Ç'ye göre) | 94 (+1 önceki Ç'ye göre) | 78 (+5 önceki Ç'ye göre) | +11.8M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $992.725.940 | 8.657.242 | 12,48% | Hisse senetleri |
| FMR LLC | $985.896.654 | 8.597.686 | 12,40% | Hisse senetleri |
| Avoro Capital Advisors LLC | $857.129.238 | 7.474.747 | 10,78% | Hisse senetleri |
| BVF INC/IL | $444.008.203 | 3.872.052 | 5,58% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $376.085.378 | 3.279.719 | 4,73% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $343.114.771 | 2.992.193 | 4,31% | Hisse senetleri |
| Siren, L.L.C. | $336.651.626 | 2.935.830 | 4,23% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $336.255.785 | 2.932.378 | 4,23% | Hisse senetleri |
| Atlas Venture Life Science Advisors, LLC | $326.527.526 | 2.847.541 | 4,11% | Hisse senetleri |
| STATE STREET CORP | $313.877.705 | 2.737.226 | 3,95% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $181.558.708 | 1.582.987 | 2,28% | Hisse senetleri |
| Capital Research Global Investors | $159.262.984 | 1.388.881 | 2,00% | Hisse senetleri |
| Driehaus Capital Management LLC | $105.408.448 | 919.233 | 1,33% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $101.597.391 | 885.998 | 1,28% | Hisse senetleri |
| Merck & Co., Inc. | $88.544.161 | 772.165 | 1,11% | Hisse senetleri |
| NORGES BANK | $86.833.399 | 757.246 | 1,09% | Hisse senetleri |
| FEDERATED HERMES, INC. | $85.933.469 | 749.398 | 1,08% | Hisse senetleri |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $84.955.104 | 740.866 | 1,07% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $81.750.884 | 981.521 | 1,03% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $77.152.155 | 672.819 | 0,97% | Hisse senetleri |
| Holocene Advisors, LP | $72.996.514 | 636.579 | 0,92% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $60.744.024 | 529.729 | 0,76% | Hisse senetleri |
| EVENTIDE ASSET MANAGEMENT, LLC | $57.811.287 | 504.210 | 0,73% | Hisse senetleri |
| JENNISON ASSOCIATES LLC | $57.676.487 | 502.978 | 0,73% | Hisse senetleri |
| Woodline Partners LP | $57.434.534 | 500.868 | 0,72% | Hisse senetleri |
| Rock Springs Capital Management LP | $51.963.399 | 453.156 | 0,65% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $51.570.654 | 449.731 | 0,65% | Hisse senetleri |
| Boxer Capital Management, LLC | $49.204.897 | 429.100 | 0,62% | Hisse senetleri |
| Pictet Asset Management Holding SA | $44.984.008 | 395.540 | 0,57% | Hisse senetleri |
| BRAIDWELL LP | $43.363.951 | 378.163 | 0,55% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $43.100.784 | 375.868 | 0,54% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $42.585.457 | 371.374 | 0,54% | Hisse senetleri |
| Clearbridge Investments, LLC | $39.815.871 | 347.221 | 0,50% | Hisse senetleri |
| Octagon Capital Advisors LP | $35.547.700 | 310.000 | 0,45% | Hisse senetleri |
| Nextech Invest Ltd. | $31.981.004 | 278.896 | 0,40% | Hisse senetleri |
| Alyeska Investment Group, L.P. | $31.701.095 | 276.455 | 0,40% | Hisse senetleri |
| TD Asset Management Inc | $31.293.443 | 272.900 | 0,39% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $29.085.378 | 373.800 | 0,37% | Hisse senetleri |
| Commodore Capital LP | $28.667.500 | 250.000 | 0,36% | Hisse senetleri |
| RTW INVESTMENTS, LP | $27.520.800 | 240.000 | 0,35% | Hisse senetleri |
| GILDER GAGNON HOWE & CO LLC | $26.265.508 | 229.053 | 0,33% | Hisse senetleri |
| Polar Capital Holdings Plc | $23.363.668 | 203.747 | 0,29% | Hisse senetleri |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $22.934.000 | 200.000 | 0,29% | Hisse senetleri |
| Candriam S.C.A. | $22.096.270 | 192.880 | 0,28% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $21.627.335 | 188.605 | 0,27% | Hisse senetleri |
| Eagle Health Investments LP | $19.052.191 | 166.148 | 0,24% | Hisse senetleri |
| Connor, Clark & Lunn Investment Management Ltd. | $17.189.950 | 149.908 | 0,22% | Hisse senetleri |
| DIADEMA PARTNERS LP | $17.166.099 | 149.700 | 0,22% | Alım opsiyonu |
| Foresite Capital Management VI LLC | $16.779.890 | 146.332 | 0,21% | Hisse senetleri |
| WCM INVESTMENT MANAGEMENT, LLC | $16.595.869 | 151.810 | 0,21% | Hisse senetleri |
| JANE STREET GROUP, LLC | $15.732.724 | 137.200 | 0,20% | Alım opsiyonu |
| Deer Management Co. LLC | $14.436.380 | 125.895 | 0,18% | Hisse senetleri |
| TimesSquare Capital Management, LLC | $14.063.183 | 168.846 | 0,18% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $13.794.801 | 120.300 | 0,17% | Alım opsiyonu |
| Caption Management, LLC | $13.760.400 | 120.000 | 0,17% | Satım opsiyonu |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $13.703.409 | 119.503 | 0,17% | Hisse senetleri |
| BOONE CAPITAL MANAGEMENT LLC | $12.977.548 | 113.173 | 0,16% | Hisse senetleri |
| ARMISTICE CAPITAL, LLC | $12.186.210 | 106.272 | 0,15% | Hisse senetleri |
| First Turn Management, LLC | $11.757.459 | 102.533 | 0,15% | Hisse senetleri |
| Ensign Peak Advisors, Inc | $11.198.672 | 97.660 | 0,14% | Hisse senetleri |
| Squarepoint Ops LLC | $11.144.663 | 97.189 | 0,14% | Hisse senetleri |
| Swiss National Bank | $10.331.767 | 90.100 | 0,13% | Hisse senetleri |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $10.262.276 | 89.494 | 0,13% | Hisse senetleri |
| Bank of New York Mellon Corp | $9.823.664 | 85.669 | 0,12% | Hisse senetleri |
| RHUMBLINE ADVISERS | $9.252.017 | 80.684 | 0,12% | Hisse senetleri |
| JPMORGAN CHASE & CO | $9.149.756 | 81.205 | 0,12% | Hisse senetleri |
| Burkehill Global Management, LP | $8.600.250 | 75.000 | 0,11% | Hisse senetleri |
| VICTORY CAPITAL MANAGEMENT INC | $8.524.567 | 74.340 | 0,11% | Hisse senetleri |
| CITIGROUP INC | $8.504.959 | 74.169 | 0,11% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $8.462.646 | 73.800 | 0,11% | Satım opsiyonu |
| CITADEL ADVISORS LLC | $8.328.253 | 72.628 | 0,10% | Hisse senetleri |
| FIFTH THIRD BANCORP | $7.529.104 | 65.659 | 0,09% | Hisse senetleri |
| BlackRock, Inc. | $7.486.231 | 65.285 | 0,09% | Hisse senetleri |
| Yiheng Capital Management, L.P. | $7.274.665 | 63.440 | 0,09% | Hisse senetleri |
| XTX Topco Ltd | $7.052.320 | 61.501 | 0,09% | Hisse senetleri |
| FIRST TRUST ADVISORS LP | $7.037.068 | 61.368 | 0,09% | Hisse senetleri |
| Atika Capital Management LLC | $6.957.488 | 60.674 | 0,09% | Hisse senetleri |
| Nicholas Investment Partners, LP | $6.257.427 | 54.569 | 0,08% | Hisse senetleri |
| Ikarian Capital, LLC | $5.779.368 | 50.400 | 0,07% | Satım opsiyonu |
| Patient Square Capital LP | $5.446.825 | 47.500 | 0,07% | Hisse senetleri |
| VANGUARD ASSET MANAGEMENT, Ltd | $5.250.281 | 45.786 | 0,07% | Hisse senetleri |
| PEREGRINE CAPITAL MANAGEMENT LLC | $5.237.094 | 45.671 | 0,07% | Hisse senetleri |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $4.687.728 | 56.282 | 0,06% | Hisse senetleri |
| UBS Group AG | $4.678.880 | 40.803 | 0,06% | Hisse senetleri |
| AXA Investment Managers S.A. | $4.558.224 | 80.534 | 0,06% | Hisse senetleri |
| VOYA INVESTMENT MANAGEMENT LLC | $4.451.260 | 38.818 | 0,06% | Hisse senetleri |
| MARSHALL WACE, LLP | $4.273.177 | 37.265 | 0,05% | Hisse senetleri |
| STATE OF WISCONSIN INVESTMENT BOARD | $4.223.640 | 36.833 | 0,05% | Hisse senetleri |
| MetLife Investment Management, LLC | $4.184.767 | 36.494 | 0,05% | Hisse senetleri |
| Rafferty Asset Management, LLC | $4.046.360 | 35.287 | 0,05% | Hisse senetleri |
| Odyssean, LLC | $3.954.395 | 34.485 | 0,05% | Hisse senetleri |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $3.851.880 | 33.591 | 0,05% | Hisse senetleri |
| CITADEL ADVISORS LLC | $3.841.445 | 33.500 | 0,05% | Satım opsiyonu |
| Aquilo Capital Management, LLC | $3.791.320 | 138.521 | 0,05% | Hisse senetleri |
| Nan Fung Group Holdings Ltd | $3.540.436 | 30.875 | 0,04% | Hisse senetleri |
| Moody Aldrich Partners LLC | $3.440.788 | 30.006 | 0,04% | Hisse senetleri |
| SEVEN GRAND MANAGERS, LLC | $3.440.100 | 30.000 | 0,04% | Hisse senetleri |
| 683 Capital Management, LLC | $3.440.100 | 30.000 | 0,04% | Satım opsiyonu |
| CITADEL ADVISORS LLC | $3.428.633 | 29.900 | 0,04% | Alım opsiyonu |
| NEW YORK STATE COMMON RETIREMENT FUND | $3.300.203 | 28.780 | 0,04% | Hisse senetleri |
Şirket yöneticileri 24 içeriden öğrenenler · 10 yöneticiler · 13 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Nello Mainolfi | Chief Executive Officer | 07 Temmuz 2026 M | 666.568 | 0 | 21 | $-34.875.625 |
| Bruce N. Jacobs | Chief Financial Officer | 30 Haziran 2026 M | 244.883 | 0 | 16 | $-13.917.105 |
| Jeremy G Chadwick | Chief Operating Officer | 27 Mayıs 2026 S | 44.018 | 0 | 29 | $-15.599.618 |
| Terence Rooney | Chief Medical Officer | 27 Temmuz 2026 A | 38.000 | 0 | 0 | $0 |
| Noah Goodman | Chief Business Officer | 01 Temmuz 2026 S | 47.179 | 0 | 9 | $-2.223.845 |
| Jared Gollob | Chief Medical Officer | 02 Mart 2026 A | 117.134 | 0 | 18 | $-9.134.491 |
| Brian Adams | Chief Legal Officer | 02 Mart 2026 A | 56.625 | 0 | 0 | $0 |
| Ellen Chiniara | Chief Legal Officer | 03 Mart 2025 A | 80.085 | 0 | 0 | $0 |
| Elaine Caughey | Chief Business Officer | 01 Mart 2023 A | 18.986 | 0 | 0 | $0 |
| Richard Chesworth | Chief Scientific Officer | 27 Ağustos 2021 M | 0 | 0 | 0 | $0 |
| Bruce Booth | Yönetim kurulu üyesi | 29 Haziran 2026 S | 462.856 | 0 | 137 | $-195.559.433 |
| Hrustanovic Gorjan | Yönetim kurulu üyesi | 24 Haziran 2026 A | — | 0 | 0 | $0 |
| Elena Ridloff | Yönetim kurulu üyesi | 24 Haziran 2026 A | 0 | 0 | 4 | $-1.285.644 |
| Pamela Esposito | Yönetim kurulu üyesi | 24 Haziran 2026 A | 1.000 | 0 | 12 | $-3.054.174 |
| Jeffrey W. Albers | Yönetim kurulu üyesi | 24 Haziran 2026 A | 0 | 0 | 3 | $-744.757 |
| Victor Sandor | Yönetim kurulu üyesi | 24 Haziran 2026 A | — | 0 | 0 | $0 |
| John Maraganore | Yönetim kurulu üyesi | 24 Haziran 2026 A | — | 0 | 0 | $0 |
| Leigh Morgan | Yönetim kurulu üyesi | 18 Haziran 2024 A | — | 0 | 0 | $0 |
| Joanna Horobin | Yönetim kurulu üyesi | 07 Haziran 2024 M | 0 | 0 | 0 | $0 |
| Donald William Nicholson | Yönetim kurulu üyesi | 15 Haziran 2022 A | — | 0 | 0 | $0 |
| Steven Edward Hall | Yönetim kurulu üyesi | 25 Ağustos 2020 C | 2.192.249 | 0 | 0 | $0 |
| Andrew Hedin | Yönetim kurulu üyesi | 20 Ağustos 2020 A | — | 0 | 0 | $0 |
| Atlas Venture Fund X, L.P. | 10% sahip | 18 Mayıs 2021 J | 5.763.012 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10% sahip | 25 Ağustos 2020 C | 959.211 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 4 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF PARTNERS L P/IL, BVF INC/IL, LAMPERT MARK N, Hrustanovic Gorjan ×2 başvurular | 26 Haziran 2026 | 6,30% | Değişiklik | — | SEC |
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker ×4 başvurular | 11 Aralık 2025 | 10,90% | Değişiklik | Sermaye yapısı | SEC |
| BIOTECHNOLOGY VALUE FUND, L.P., BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II, L.P., BVF II GP LLC, BIOTECHNOLOGY VALUE TRADING FUND OS, L.P., BVF PARTNERS OS LTD., BVF GP HOLDINGS LLC, BVF PARTNERS L.P., BVF INC., MARK N. LAMPERT, GORJAN HRUSTANOVIC ×5 başvurular | 09 Ocak 2024 | — | İlk başvuru | — | SEC |
| Vertex Pharmaceuticals Incorporated ×2 başvurular | 05 Haziran 2023 | — | İlk başvuru | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 64 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 4,23% | 84.154 NS | 31 Mayıs 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 1,99% | 10.000 NS | 31 Mayıs 2026 | N-PORT |
| HAPS · Harbor ETF Trust | 1,76% | 34.157 NS | 30 Nisan 2026 | N-PORT |
| GURU · Global X Funds | 1,04% | 7.506 NS | 30 Nisan 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,93% | 59.553 NS | 30 Nisan 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,67% | 3.077 NS | 30 Nisan 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,60% | 4.477 SH | 08 Ağustos 2026 | Günlük |
| IBB · iShares Trust | 0,58% | 522.187 SH | 08 Ağustos 2026 | Günlük |
| MMSC · First Trust Exchange-Traded Fund VI… | 0,50% | 3.204 NS | 31 Mayıs 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,39% | 24.697 NS | 30 Nisan 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,35% | 55.351 SH | 08 Ağustos 2026 | Günlük |
| IWO · iShares Trust | 0,34% | 469.031 SH | 08 Ağustos 2026 | Günlük |
| BIB · ProShares Trust | 0,33% | 3.017 NS | 31 Mayıs 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 0,33% | 1.305 NS | 31 Mayıs 2026 | N-PORT |
| ESSC · Strategy Shares | 0,31% | 979 NS | 30 Nisan 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,23% | 20.749 NS | 30 Nisan 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,22% | 360.394 SH | 08 Ağustos 2026 | Günlük |
| VBK · VANGUARD INDEX FUNDS | 0,21% | 871.540 SH | 08 Ağustos 2026 | Günlük |
| IWM · iShares Trust | 0,21% | 1.586.740 SH | 08 Ağustos 2026 | Günlük |
| BKSE · BNY Mellon ETF Trust | 0,19% | 1.938 NS | 30 Nisan 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,19% | 32.324 SH | 08 Ağustos 2026 | Günlük |
| RSSL · Global X Funds | 0,14% | 24.820 NS | 30 Nisan 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,13% | 21.796 NS | 30 Nisan 2026 | N-PORT |
| ITWO · ProShares Trust | 0,12% | 2.699 NS | 31 Mayıs 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,11% | 6.792 NS | 30 Nisan 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,11% | 294.706 NS | 31 Mayıs 2026 | N-PORT |
| ISCV · iShares Trust | 0,09% | 5.956 SH | 08 Ağustos 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | 0,09% | 1.509.269 SH | 08 Ağustos 2026 | Günlük |
| ISCG · iShares Trust | 0,09% | 8.334 SH | 08 Ağustos 2026 | Günlük |
| ISCB · iShares Trust | 0,09% | 2.398 SH | 08 Ağustos 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,08% | 22.424 SH | 08 Ağustos 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,08% | 143.695 NS | 30 Nisan 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,08% | 726.357 SH | 08 Ağustos 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,08% | 9.461 SH | 08 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,08% | 134.854 SH | 08 Ağustos 2026 | Günlük |
| ESML · iShares Trust | 0,08% | 21.257 SH | 08 Ağustos 2026 | Günlük |
| IWN · iShares Trust | 0,07% | 101.814 SH | 08 Ağustos 2026 | Günlük |
| UWM · ProShares Trust | 0,07% | 2.111 NS | 31 Mayıs 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,06% | 21.910 NS | 30 Nisan 2026 | N-PORT |
| URTY · ProShares Trust | 0,05% | 2.136 NS | 31 Mayıs 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,05% | 61 NS | 31 Mayıs 2026 | N-PORT |
| WSML · iShares Trust | 0,05% | 2.882 SH | 08 Ağustos 2026 | Günlük |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 5.327 NS | 31 Mayıs 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,03% | 1.604 NS | 31 Mayıs 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,02% | 2.239 NS | 31 Mayıs 2026 | N-PORT |
| HDG · ProShares Trust | 0,02% | 54 NS | 31 Mayıs 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,02% | 93.115 NS | 30 Nisan 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 19.514 NS | 31 Mayıs 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 675 NS | 30 Nisan 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 2.916 NS | 30 Nisan 2026 | N-PORT |